Box score
Latigo Biotherapeutics, Inc.
Reported $50M sold in a new Form D filed February 13, 2025 (Thousand Oaks, California).
- Biggest raise
- $50M filed Feb 13, 2025
- League
- Bio & Health Biotechnology
- Based in
- Thousand Oaks, California
- Season rank
- #74 of 1,311 in the Bio & Health League; #474 of 12,397 overall (2025)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-02-13 | New notice | $50M | $150M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 2056611.
Similar raises, 2025
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Akura Medical, Inc. | Bio & Health | $51.4M |
| 2 | HeartFlow Holding, Inc. | Bio & Health | $50M |
| 3 | Hyperion Defi, Inc. | Bio & Health | $50M |
| 4 | Spruce Biosciences, Inc. | Bio & Health | $50M |
| 5 | Alto Neuroscience, Inc. | Bio & Health | $50M |
| 6 | HeartFlow Holding, Inc. | Bio & Health | $48.4M |